Targets of Acquired Tick-Resistance As Anti-Tick Vaccines

Information

  • Research Project
  • 9966871
  • ApplicationId
    9966871
  • Core Project Number
    R41AI145778
  • Full Project Number
    5R41AI145778-02
  • Serial Number
    145778
  • FOA Number
    PA-18-575
  • Sub Project Id
  • Project Start Date
    7/1/2019 - 5 years ago
  • Project End Date
    6/30/2021 - 3 years ago
  • Program Officer Name
    ILIAS, MALIHA R
  • Budget Start Date
    7/1/2020 - 4 years ago
  • Budget End Date
    6/30/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    02
  • Suffix
  • Award Notice Date
    6/23/2020 - 4 years ago
Organizations

Targets of Acquired Tick-Resistance As Anti-Tick Vaccines

ABSTRACT This proposal seeks to develop a novel vaccine against pathogens transmitted by the blacklegged tick, Ixodes scapularis, by targeting tick salivary proteins (Salps) critical for tick feeding. I. scapularis Salps provide functions critical for evading host defense responses detrimental to the tick. Further, these salivary functions are also co-opted by tick-transmitted pathogens to ensure their survival in the host. We reason that tick Salps critical for tick feeding might serve as vaccine targets to impair tick feeding and consequently, also thwart the transmission of multiple tick-borne pathogens. Our hypothesis is validated by the phenomenon of acquired tick-resistance wherein, upon repeated tick infestations non-permissive hosts such as rabbits, and guinea pigs mount a robust immune response against tick Salps critical for tick feeding and this results in rapid rejection of ticks. Tick-resistance has also been shown to prevent transmission of B. burgdorferi. Exploiting this phenomenon, we have identified several Salps that are avidly recognized by tick-resistant animal sera. Since tick-resistant sera recognize multiple Salps it is reasonable to expect that multiple immunodominant Salps might have to be targeted simultaneously to recapitulate tick-resistance and achieve robust tick rejection. In this research study, we will: 1. Assess the vaccine potential of a combination of immunodominant Salps to prevent tick feeding in conjunction with adjuvants approved for human use. 2. Examine the utility of simultaneously targeting multiple immunodominant tick Salps to prevent the transmission of two tick-transmitted pathogens, B. burgdorferi and A. phagocytophilum. This combination strategy targeting multiple Salps simultaneously has the potential to result in a vaccine that might block the transmission of multiple I. scapularis- borne pathogens.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R41
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    296626
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:296626\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    L2 DIAGNOSTICS, LLC
  • Organization Department
  • Organization DUNS
    142406110
  • Organization City
    NEW HAVEN
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    065300175
  • Organization District
    UNITED STATES